Cite
HARVARD Citation
Oh, C. et al. (2018). A Randomized, Double-blind, Active-controlled Clinical Trial of a Cell Culture-derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age. Pediatric infectious disease journal. 37 (6), p. . [Online].